Cerebrospinal Fluid

3

Review clinical trials related to Cerebrospinal Fluid. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics

The goal of this study is to uncover the molecular mechanisms responsible for secondary brain injury in patients with post-cardiac arrest syndrome by analyzing cerebrospinal fluid (CSF) using multi-omics techniques. The main question this study aims to answer is: Which genome-, transcriptome-, proteome-, and metabolome-level changes in CSF are associated with secondary brain injury after cardiac arrest? To address this question, CSF samples collected from post-cardiac arrest patients will undergo multi-omics analyses. Identified molecular pathways will be used to screen existing drug databases and generate new therapeutic candidates through computational modeling and compound synthesis. These findings will provide the scientific foundation needed to design and implement future preclinical experiments using cardiac arrest animal models.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chungnam National University HospitalUpdated: Mar 18, 2026Locations: 1Duration: 3 Months
Eligibility criteria

Patients receiving post-resuscitation care after out-of-hospital cardiac arrest... [+9]

Cerebral Edema: Patients with evidence of cerebral edema on a brain computed tom... [+3]

Status: Recruiting

Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.

Idiopathic intracranial hypertension (HTICi) is a pathology, affecting young adults with a predominance of women, due to an increase in intracranial pressure, which may be associated with stenosis of the cerebral venous sinuses and whose origin remains unknown. This hypertension can lead to papillary edema (OP) which can lead to a narrowing of the visual field and progress to blindness. Along with weight reduction, acetazolamide, which reduces the production of cerebrospinal fluid (CSF), is prescribed as a first-line treatment. Its efficacy is inconsistent in resolving papillary edema and there are many side effects. In the event of ineffectiveness or dependence on acetazolamide associated with hygiene and dietetic rules, a second line of therapy is then considered: neurosurgical (internal shunt of the LCS) or endovascular (venous stenting) treatment. These invasive techniques have each proven their effectiveness in the rapid and permanent resorption of OP, allowing improvement or preservation of visual function. In terms of induced morbidity, the superiority of one technique over the other, if it exists, has not been established. Our objective is to compare the efficacy, safety, and safety of LCS bypass surgery versus venous sinus stenting in HTICi with moderate to severe visual impairment after failure of medical treatment defined by the absence of resorption of the OP after several months

Participants needed: 276
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Fondation Ophtalmologique Adolphe de RothschildUpdated: Jan 5, 2026Locations: 1
Eligibility criteria

Patient aged 18 or over [+5]

Fulminant HTICi [+3]

Status: Recruiting

Comparison of Different CSF Sampling Sites on External Ventricular Drains

The aim of the current study is to evaluate the difference between proximal and distal CSF sampling. If the characteristics of distally and proximally sampled CSF are similar or correlate well, it may be possible to only sample CSF distally in the future, thereby avoiding the risks mentioned above.

Participants needed: 55
Trial details
Biological sex: AllType: ObservationalSponsor: Universitaire Ziekenhuizen KU LeuvenUpdated: Jul 1, 2024Locations: 1
Eligibility criteria

Patients with an EVD in place regardless of the underlying pathology. [+1]

Patients in whom the removal of the drain is planned within 48 hours, before rou...